Hims’ Super Bowl fallout, and the FDA reverses course
-
By
-
Allison DeAngelis
-
Elaine Chen
-
Adam Feuerstein
-
February 19, 2026
-
Clinical Scorecard: Aftermath of Hims' Super Bowl Advertisement and FDA's Policy Shift
At a Glance
| Category | Detail |
|---|
| Condition | Regulatory implications of advertising in healthcare, specifically related to telehealth and psychedelic treatments |
| Key Mechanisms | Impact of advertising on regulatory scrutiny and policy changes, particularly in the context of recent high-profile cases |
| Target Population | Healthcare providers, pharmaceutical companies, patients, and telehealth service users |
| Care Setting | Telehealth and pharmaceutical industry, with emphasis on emerging therapies |
Key Highlights
- Discussion on Hims' GLP-1 pill fallout and its implications for advertising regulations
- Regulatory implications of Hims' Super Bowl ad and its impact on future advertising practices
- Updates on Moderna's influenza vaccine application and FDA's response
- Insights into Compass Pathways' depression psychedelic data and its regulatory considerations
- Potential crackdown on compounding practices in light of recent advertising scrutiny
Guideline-Based Recommendations
Diagnosis
- Consider regulatory guidelines when diagnosing conditions related to advertised treatments
Management
- Implement strategies to ensure compliance with advertising regulations in treatment plans
Monitoring & Follow-up
- Regularly review FDA updates and guidance related to advertised therapies
Risks
- Increased regulatory scrutiny following high-profile advertisements
Patient & Prescribing Data
Patients seeking telehealth services and psychedelic treatments, particularly for depression
Emerging data on psychedelic therapies for depression, including clinical trial results and patient outcomes
Clinical Best Practices
- Ensure compliance with advertising regulations and ethical standards
- Monitor changes in FDA guidance closely to adapt practices accordingly
- Evaluate the impact of advertising on patient perceptions and treatment decisions
References
